Epidermal Growth Factor (EGF) Protein Protein
- Protein Type
Escherichia coli (E. coli)
- Urogastrone, URG
- Epidermal Growth Factor purity was determined to be greater than 95% as determined by analysis by HpLC, UV-Spectroscopy at 280nm and by reducing and non-reducing SDS-pAGE.
- Endotoxin Level
- Low endotoxin
Epidermal Growth Factor (EGF) (Active) protein Protein
EGF Origin: Human Host: Escherichia coli (E. coli) > 95 % as determined by (a) Analysis by SEC-HPLC (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel Active
- Application Notes
Application Note: Epidermal Growth Factor Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Epidermal Growth Factor in immunological assays.
Other Performance Data: Endotoxin Level: Measured by kinetic LAL analysis and is typically ≤ 1 EU/μg protein. Biologic Activity: The activity is determined by the dose-dependent proliferation of mouse BALB/c 3T3 cells and is typically less than 0.1 ng/mL.
- For Research Use only
Reconstitution Volume: 20 μL (20-200 μL)
Reconstitution Buffer: Restore with deionized water (or equivalent)
Buffer: 0.01 M Sodium Phosphate, pH 7.5
- Without preservative
- RT,4 °C,-20 °C
- Expiry Date
- 6 months
- HOMG4, URG, AI790464, CEGF, epidermal growth factor, pro-epidermal growth factor, EGF, egf, CpipJ_CPIJ020278, Egf
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation